• The Government of India has decided to waive off some GST amount against the import of gene therapy — Zolgensma.

“PSIR Answer Writing” course visit www.upschacks.com

• This therapy is required to treat a child who is suffering from Spinal Muscular Atrophy.
• Zolgensma Gene therapy which replaces the faulty gene. US regulators approved this therapy in May 2019.
• Zolgensma works by supplying a healthy copy of the faulty gene. It allows nerve cells to then start producing the needed protein.
• This halts the deterioration of the nerve cells and allows the baby to grow more normally.